
Loan & Debt6 Oct 2026, 10:33 am
Ajanta Pharma Promoter Creates Pledge for NCD Issue
AI Summary
Aayush Agrawal, trustee of Aayush Agrawal Trust and a promoter of Ajanta Pharma Limited, has created a pledge on 4,60,000 equity shares. This action is to facilitate the issuance of Non-Convertible Debentures (NCDs). The disclosure was made on October 5, 2026, in accordance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. This move indicates a financing activity by the promoter, potentially to raise capital through debt instruments.
Key Highlights
- Promoter Aayush Agrawal pledged 4,60,000 Ajanta Pharma shares.
- Pledge created for the purpose of issuing Non-Convertible Debentures (NCDs).
- Disclosure filed under SEBI (SAST) Regulations, 2011.
- This is a promoter-level financing activity.
- No change in beneficial ownership is implied by the pledge.
Price Impact
More from AJANTPHARM